AGTR1 and COVID-19: Finally, other compounds that may be useful for the treatment of COVID-19, but not currently evaluated, are molecules that may adjust the imbalance between AT1 and AT2 receptors such as compound 21 (C-21), CGP-42112A, and L-163491 (26).